CAD-204520

N/A

Report date: 2023/04/25 09:12:37
NME

Base Information

Drug NameCAD-204520
Drug Alias NameCad-204520CAD-204520
ClassificationSmall molecules
Mechanisms of ActionSarcoplasmic reticulum calcium-transporting ATPases inhibitorsApoptosis stimulants
TargetsSarcoplasmic reticulum calcium-transporting ATPases
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCaDo Biotechnology IvS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A